Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News Latest research finds hypertension drug could be repurposed to delay ageing Latest research has found that rilmenidine, a drug used to treat hypertension, can be used to slow ageing and extend lifespan.
News Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship
News Latest study uncovers findings of periodontal therapy in reducing rheumatoid arthritis disease activity
03 September 2021 New study will use artificial intelligence to improve treatments for people with multiple long-term conditions The NIHR has awarded £2.5 million for research that will use artificial intelligence to produce computer programmes and tools to help doctors improve the choice of drugs in patients with multiple long-term conditions.
27 August 2021 New spinout Empower Therapeutics sets its sights on reducing pain 'chronification' The University of Birmingham, UK, and the University of Maryland, Baltimore have created a new spinout, Empower Therapeutics, to commercialise a simple, reliable (EEG)-based biomarker for pain sensitivity.
24 August 2021 Birmingham Health Partners plays key role in report calling for Government reform of regulation of medical devices Experts within Birmingham Health Partners have significantly contributed to a new independent report calling on the UK Government to reform the regulation of medical devices.
16 August 2021 New clinical risk management tools are needed to prevent COVID-19 deaths, say experts A new study exposes the dire need for new clinical risk management tools to help hospital healthcare workers prevent the deaths and intensive care admissions of BAME COVID-19 patients with pneumoni.
12 August 2021 Researcher shows the importance of work with patient research partners to dissect research question Dr Amy Naylor is a Senior Research Fellow and member of the Rheumatology Research Group within the Institute of Inflammation and Ageing.
22 July 2021 Rheumatology Research Group awarded five year EULAR Centre of Excellence Status In July 2021, the University of Birmingham's Rheumatology Research Group (RRG) was awarded five year EULAR Centre of Excellence Status for the second time in a row.